Effects of cannabidiol on locomotor activity

F Calapai, L Cardia, G Calapai, D Di Mauro… - Life, 2022 - mdpi.com
Cannabidiol (CBD) is the second cannabinoid, in order of importance after Δ9-
tetrahydrocannabinol (THC), from Cannabis sativa. Unlike THC, CBD does not cause …

Vasoprotective endothelial effects of chronic cannabidiol treatment and its influence on the endocannabinoid system in rats with primary and secondary hypertension

M Baranowska-Kuczko, H Kozłowska, M Kloza… - Pharmaceuticals, 2021 - mdpi.com
Our study aimed to examine the endothelium (vascular)-protecting effects of chronic
cannabidiol (CBD) administration (10 mg/kg once daily for 2 weeks) in aortas and small …

Vasoactive and Antifibrotic Properties of Cannabinoids and Applications to Vasospastic/Vaso-Occlusive Disorders: A Systematic Review

G Li, J Choi, KL Stephens… - Annals of Plastic …, 2024 - journals.lww.com
Background Management of vasospastic and vaso-occlusive disorders is a complex
challenge, with current treatments showing varied success. Cannabinoids have …

Pharmacological characterisation of the CB1 receptor antagonist activity of cannabidiol in the rat vas deferens bioassay

AC Mazeh, JA Angus, CE Wright - European Journal of Pharmacology, 2021 - Elsevier
Cannabidiol is increasingly considered for treatment of a wide range of medical conditions.
Binding studies suggest that cannabidiol binds to CB 1 receptors. In the rat isolated vas …

[PDF][PDF] Vasculoprotective properties of Δ9-tetrahydrocannabivarin (THCV) in diabetes type-2 in-duced microangiopathies of hepatic vessels in mice

H Oberthaler - 2021 - eplus.uni-salzburg.at
Diabetes mellitus of type 2 accounts for 90% of diabetic cases worldwide, which makes it the
predominant form of diabetes. Its clinical hallmarks are pancreatic β-cell dysfunction, chronic …

[引用][C] New CBD Integrated Treatments Based on Recent Scientific Literature and Clinical Practice New CBD Integrated Treatments Based on Recent Scientific …

CD Meletis